Vaspin, a visceral adipose tissue-derived serine protease inhibitor, was discovered in 2005 in visceral white adipose tissue of Otsuka Long-Evans Tokushima fatty (OLETF) rats, which are an animal model for the study of obesity and type 2 diabetes [15]. This evidence concerns the gene SERPINA12 and obesity disorder.